BetterScholar BetterScholar
13
Role
Title
Level Year L/R
🐜 Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
19 auth. R. Herbst, P. Baas, Dong-Wan Kim, E. Felip, J. PΓ©rez-Gracia, Ji-Youn Han, J. Molina, Joo‐Hang Kim, C. D. Arvis, M. Ahn, ... M. Majem, M. Fidler, G. Castro, M. Garrido, G. Lubiniecki, Shentu Yue, E. Im, M. Dolled-Filhart, E. Garon
12 2016
12
🐜
🦁 Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.
J. Molina, Ping Yang, S. Cassivi, S. Schild, A. Adjei
11 2008
11
🦁
🐒 Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment.
N. Duma, R. Santana-Davila, J. Molina
10 2019
10
🐒
🐜 Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis.
19 auth. Yucai Wang, Shouhao Zhou, Fang Yang, Xinyue Qi, Xin Wang, X. Guan, Chan Shen, N. Duma, Jesus Vera Aguilera, A. Chintakuntlawar, ... K. Price, J. Molina, L. Pagliaro, T. Halfdanarson, A. Grothey, S. Markovic, G. Nowakowski, S. Ansell, Michael L. Wang
9 2019
9
🐜
🐜 Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.
20 auth. A. Adjei, R. Cohen, W. Franklin, C. Morris, David M. Wilson, J. Molina, L. Hanson, L. Gore, L. Chow, S. Leong, ... L. Maloney, G. Gordon, Heidi Simmons, A. Marlow, K. Litwiler, Suzy A. Brown, G. Poch, K. Kane, J. Haney, S. Eckhardt
9 2008
9
🐜
🐜 Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.
19 auth. K. Bible, V. Suman, J. Molina, R. Smallridge, W. Maples, M. Menefee, J. Rubin, K. Sideras, J. Morris, B. Mciver, ... Jill K. Burton, Kevin P. Webster, C. Bieber, A. Traynor, P. Flynn, B. Goh, Hui Tang, S. Ivy, C. Erlichman
8 2010
8
🐜
🐜 Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.
10 auth. A. Visbal, B. Williams, F. Nichols, R. Marks, J. Jett, M. Aubry, ... E. Edell, J. Wampfler, J. Molina, Ping Yang
8 2004
8
🐜
🐜 Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors
12 auth. P. Haluska, H. Shaw, G. Batzel, D. Yin, J. Molina, L. R. Molife, ... T. Yap, M. Roberts, Amarnath Sharma, A. Gualberto, A. Adjei, J. D. de Bono
8 2007
8
🐜
🦁 The Ras/Raf/MAPK pathway.
J. Molina, A. Adjei
7 2006
7
🦁
🐜 NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018.
32 auth. G. Kalemkerian, B. Loo, W. Akerley, A. Attia, M. Bassetti, Y. Boumber, R. Decker, M. Dobelbower, A. Dowlati, R. Downey, Charles Florsheim, A. Ganti, J. Grecula, M. Gubens, C. Hann, ... J. Hayman, R. Heist, M. Koczywas, R. Merritt, N. Mohindra, J. Molina, C. Moran, D. Morgensztern, S. Pokharel, D. Portnoy, D. Rhodes, C. Rusthoven, J. Sands, R. Santana-Davila, Charles C. Williams, Karin G. Hoffmann, M. Hughes
7 2018
7
🐜
🐜 Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
34 auth. A. Ganti, B. Loo, M. Bassetti, C. Blakely, A. Chiang, T. D’amico, C. D'Avella, A. Dowlati, R. Downey, M. Edelman, Charles Florsheim, K. Gold, J. Goldman, J. Grecula, C. Hann, ... W. Iams, P. Iyengar, K. Kelly, M. Khalil, M. Koczywas, R. Merritt, N. Mohindra, J. Molina, C. Moran, S. Pokharel, S. Puri, A. Qin, C. Rusthoven, J. Sands, R. Santana-Davila, M. Shafique, S. Waqar, K. Gregory, M. Hughes
7 2021
7
🐜
🐜 Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis.
10 auth. M. Fernandez-Zapico, Natalia C Gonzalez-Paz, Ellen A Weiss, Doris N. Savoy, J. Molina, R. Fonseca, ... T. Smyrk, S. Chari, R. Urrutia, D. Billadeau
7 2005
7
🐜
🦁 Primary salivary gland‐type lung cancer
8 auth. J. Molina, M. Aubry, Jean E. Lewis, J. Wampfler, Brent A. Williams, D. Midthun, ... Ping Yang, S. Cassivi
7 2007
7
🦁